Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025651339> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2025651339 endingPage "279" @default.
- W2025651339 startingPage "275" @default.
- W2025651339 abstract "Abstract Background A previous study with azelastine nasal spray in patients with seasonal allergic rhinitis (SAR) demonstrated that increasing the azelastine concentration from 0.1% to 0.15% allowed for once‐daily dosing without increasing the incidence of adverse effects. This study evaluated the efficacy of azelastine 0.15% nasal spray administered once daily for treating symptoms of SAR. Methods In this 14‐day, randomized, double‐blind, placebo‐controlled study, patients with moderate‐to‐severe SAR were randomized to azelastine 0.15% (n = 251) or placebo (n = 255), both at a dosage of 2 sprays/nostril once daily. The primary efficacy variable was change from baseline in the 12‐hour reflective Total Nasal Symptom Score (TNSS). Key secondary variables were change from baseline in 24‐hour instantaneous TNSS, to establish the dosing interval, and change from baseline in the Total Ocular Symptom Score (TOSS). Results The mean improvement (3.57) and percentage improvement (19.3%) in 12‐hour reflective TNSS was significant ( p < 0.012) with azelastine 0.15% compared to placebo (2.14 and 11.4%, respectively). The mean improvement in 24‐hour instantaneous TNSS was also significant ( p < 0.001) for azelastine 0.15% compared to placebo, indicating efficacy with once‐daily dosing. The overall improvement and percentage improvement in TOSS was significant ( p ≤ 0.012) with azelastine 0.15% (2.21 and 16.7%, respectively) compared to placebo (1.28 and 6.0%, respectively). The overall score for the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) was significantly ( p < 0.001) improved from baseline in the azelastine group compared with the placebo group. Nasal discomfort (3.6%) and bitter taste (2.4%) were the most common adverse events. There were no reports of somnolence with azelastine. Conclusion Azelastine 0.15% was effective and well tolerated with once‐daily dosing. Azelastine 0.15% nasal spray significantly improved a complex of eye symptoms compared to placebo. © 2011 ARS‐AAOA, LLC." @default.
- W2025651339 created "2016-06-24" @default.
- W2025651339 creator A5003069377 @default.
- W2025651339 creator A5020623335 @default.
- W2025651339 creator A5053514017 @default.
- W2025651339 creator A5064205091 @default.
- W2025651339 date "2011-05-09" @default.
- W2025651339 modified "2023-10-17" @default.
- W2025651339 title "Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen" @default.
- W2025651339 cites W1968323955 @default.
- W2025651339 cites W1990969825 @default.
- W2025651339 cites W1993588023 @default.
- W2025651339 cites W2008955505 @default.
- W2025651339 cites W2025071774 @default.
- W2025651339 cites W2036273262 @default.
- W2025651339 cites W2058432012 @default.
- W2025651339 cites W2070694817 @default.
- W2025651339 cites W2074558244 @default.
- W2025651339 cites W2079984901 @default.
- W2025651339 cites W2080515725 @default.
- W2025651339 cites W2082769846 @default.
- W2025651339 cites W2087659881 @default.
- W2025651339 cites W2109893012 @default.
- W2025651339 cites W2119539558 @default.
- W2025651339 cites W2155701010 @default.
- W2025651339 cites W2166275592 @default.
- W2025651339 doi "https://doi.org/10.1002/alr.20065" @default.
- W2025651339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22287431" @default.
- W2025651339 hasPublicationYear "2011" @default.
- W2025651339 type Work @default.
- W2025651339 sameAs 2025651339 @default.
- W2025651339 citedByCount "7" @default.
- W2025651339 countsByYear W20256513392013 @default.
- W2025651339 countsByYear W20256513392014 @default.
- W2025651339 countsByYear W20256513392016 @default.
- W2025651339 countsByYear W20256513392018 @default.
- W2025651339 countsByYear W20256513392019 @default.
- W2025651339 countsByYear W20256513392022 @default.
- W2025651339 countsByYear W20256513392023 @default.
- W2025651339 crossrefType "journal-article" @default.
- W2025651339 hasAuthorship W2025651339A5003069377 @default.
- W2025651339 hasAuthorship W2025651339A5020623335 @default.
- W2025651339 hasAuthorship W2025651339A5053514017 @default.
- W2025651339 hasAuthorship W2025651339A5064205091 @default.
- W2025651339 hasConcept C126322002 @default.
- W2025651339 hasConcept C141071460 @default.
- W2025651339 hasConcept C142724271 @default.
- W2025651339 hasConcept C168563851 @default.
- W2025651339 hasConcept C197934379 @default.
- W2025651339 hasConcept C204787440 @default.
- W2025651339 hasConcept C27081682 @default.
- W2025651339 hasConcept C2777288759 @default.
- W2025651339 hasConcept C2778311950 @default.
- W2025651339 hasConcept C2779789940 @default.
- W2025651339 hasConcept C2780113039 @default.
- W2025651339 hasConcept C2780973058 @default.
- W2025651339 hasConcept C42219234 @default.
- W2025651339 hasConcept C71924100 @default.
- W2025651339 hasConcept C85663871 @default.
- W2025651339 hasConcept C98274493 @default.
- W2025651339 hasConceptScore W2025651339C126322002 @default.
- W2025651339 hasConceptScore W2025651339C141071460 @default.
- W2025651339 hasConceptScore W2025651339C142724271 @default.
- W2025651339 hasConceptScore W2025651339C168563851 @default.
- W2025651339 hasConceptScore W2025651339C197934379 @default.
- W2025651339 hasConceptScore W2025651339C204787440 @default.
- W2025651339 hasConceptScore W2025651339C27081682 @default.
- W2025651339 hasConceptScore W2025651339C2777288759 @default.
- W2025651339 hasConceptScore W2025651339C2778311950 @default.
- W2025651339 hasConceptScore W2025651339C2779789940 @default.
- W2025651339 hasConceptScore W2025651339C2780113039 @default.
- W2025651339 hasConceptScore W2025651339C2780973058 @default.
- W2025651339 hasConceptScore W2025651339C42219234 @default.
- W2025651339 hasConceptScore W2025651339C71924100 @default.
- W2025651339 hasConceptScore W2025651339C85663871 @default.
- W2025651339 hasConceptScore W2025651339C98274493 @default.
- W2025651339 hasIssue "4" @default.
- W2025651339 hasLocation W20256513391 @default.
- W2025651339 hasLocation W20256513392 @default.
- W2025651339 hasOpenAccess W2025651339 @default.
- W2025651339 hasPrimaryLocation W20256513391 @default.
- W2025651339 hasRelatedWork W2006854382 @default.
- W2025651339 hasRelatedWork W2011769776 @default.
- W2025651339 hasRelatedWork W2025422535 @default.
- W2025651339 hasRelatedWork W2076100225 @default.
- W2025651339 hasRelatedWork W2079823755 @default.
- W2025651339 hasRelatedWork W2084304346 @default.
- W2025651339 hasRelatedWork W2094714974 @default.
- W2025651339 hasRelatedWork W2337335142 @default.
- W2025651339 hasRelatedWork W2373495417 @default.
- W2025651339 hasRelatedWork W2384475503 @default.
- W2025651339 hasVolume "1" @default.
- W2025651339 isParatext "false" @default.
- W2025651339 isRetracted "false" @default.
- W2025651339 magId "2025651339" @default.
- W2025651339 workType "article" @default.